Jo Varshney

CEO/Founder + STEM PhD +Vet

[Jo Varshney @jo_verisim]

Thank you for the shout out!

[Intel Capital @intelcapital]

The Infinite Machine Learning podcast featured @VeriSIMlife CEO and Founder Dr. Jo Varshney (@jo_verisim) on an episode covering #biosimulation for #drugdevelopment. Listen to the full episode below to learn more about the future of #AI powered drug discovery:

[Jo Varshney @jo_verisim]

@VeriSIMlife @TheStevieAwards Thank you @TheStevieAwards, for this honor & appreciation for recognizing our work!

[VeriSIM Life @VeriSIMlife]

Proud to announce that CEO & Founder Dr. Jo Varshney (@jo_verisim) won Gold for the 20th Annual @TheStevieAwards for Women in Business, earning the title "Most Innovative Woman of the Year - Healthcare!" https://t.co/zMCwC5YK8J

[Intel Capital @intelcapital]

Founder and CEO of @VeriSIMlife Dr. Jo Varshney (@jo_verisim) discusses AI’s role in #drugdevelopment, the impending #healthcare revolution and how #AI can eliminate underpowered clinical trials. More in @medicine_maker:

[Jo Varshney @jo_verisim]

Thank you @wvce_tech, for the incredible opportunity alongside such inspiring women!

[Newton Venture Program @NewtonProgramVC]

Inspirational stories from the founders of some incredible STEM companies. Definitely check them out! 🚀

#WVCE2023Summit

[Jo Varshney @jo_verisim]

Thank you @ClarivateHealth for the shout out!

[Clarivate for Life Sciences & Healthcare @ClarivateHealth]

Read how #AI can de-risk #drugdevelopment and increase approvals, in a new article written by Dr. Jo Varshney, Founder and CEO of @VeriSIMlife which publised in Forbes, here https://t.co/ktMHTACKSm

[Jo Varshney @jo_verisim]

🚀 Exciting News! I'm thrilled to announce that I'll be speaking at the @wvce_tech Summit at Station F Paris on October 2nd & 3rd. 🗓️
🌟 Join me and an incredible lineup of industry leaders, investors, GPs, LPs and innovators 🌟
Let's change the industry together! #WVC23Summit

[Jo Varshney @jo_verisim]

@VeriSIMlife @Support @elonmusk @jo_getter Frustrated with no response, ended up creating a new profile...